Reduced COX-2 protein in colorectal cancer with defective mismatch repair

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5473-5477

  Karnes Jr , William E ^a   Shattuck Brandt, Rebecca ^b   Burgart, Lawrence J ^a   DuBois, Raymond N ^b   Tester, David J ^a   Cunningham, Julie M ^a   Kim, Cheong Yong ^a   McDonnell, Shannon K ^a   Schaid, Daniel J ^a   Thibodeau, Stephen N ^a  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DNA REPAIR; FRAMESHIFT MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROSPECTIVE STUDIES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS;

EID: 3643084354     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. American Cancer Society. Cancer Facts and Figures-1996, pp. 5008-5096. Atlanta, GA: American Cancer Society, 1996.
2. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
3. Thun, M. J., Namboodiri, M. M., and Heath, C. W., Jr. Asprin use and reduced risk of colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
4. Logan, R. F., Little, J., Hawtin, P. G., and Hardcastle, J. D. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br. Med. J., 307: 285-289, 1993.
5. Donnelly, M. T., and Hawkey, C. J. Review article: COX-II inhibitors - a new generation of safer NSAIDs? Aliment. Pharmacol. Ther., 11: 227-236, 1997.
6. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
7. Rigas, B., Goldman, I. S., and Levine, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122: 518-523, 1993.
8. Giardiello, F. M., Spannhake, E. W., DuBois, R. N., Hylind, L. M., Hubbard, W. C., Hamilton, S. R., and Yang, V. W. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. Gastroenterology, 112: A568, 1997.
9. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
10. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
11. Roy, H. K., and Lu, K. Nabumetone inhibition of intestinal tumorogenesis in MIN mice: modulation of Bcl-2. Gastroenterology, 112: A647, 1997.
12. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
13. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998.
14. Polakis, P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim. Biophys. Acta, 1332: F127-F147, 1997.
15. Marra, G., and Boland, C. R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst., 87: 1114-1125, 1995.
16. Eshleman, J. R., and Markowitz, S. D. Microsatellite instability in inherited and sporadic neoplasms. Curr. Opin. Oncol., 7: 83-89, 1995.
17. Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., Jass, J. R., Dunlop, M., Wyllie, A., Peltomaki, P., de la Chapelle, A., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat. Med., 2: 169-174, 1996.
18. Peltomaki, P., and Vasen, H. F. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology, 113: 1146-1158, 1997.
19. Papadopoulos, N., and Lindblom, A. Molecular basis of HNPCC: mutations of MMR genes. Hum. Mutat., 10: 89-99, 1997.
20. Thibodeau, S. N., French, A. J., Cunningham, J. M., Tester, D., Burgart, L. J., Roche, P. C., McDonnell, S. K., Schaid, D. J., Vockley, C. W., Michels, V. V., Farr, G. H. J., and O'Connell, M. J. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res., 58: 1713-1718, 1998.
21. Dietmaier, W., Wallinger, S., Bocker, T., Kullmann, F., Fishel, R., and Ruschoff, J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res., 57: 4749-4756, 1997.
22. Thibodeau, S. N., French, A. J., Roche, P. C., Cunningham, J. M., Tester, D. J., Lindor, N. M., Moslein, G., Baker, S. M., Liskay, R. M., Burgart, L. J., Honchel, R., and Halling, K. C. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res., 56: 4836-4840, 1996.
23. Thibodeau, S. N., Bren, G., and Schaid, D. Microsatellite instability in cancer of the proximal colon. Science, 260: 816-819, 1993.
24. Bubb, V. J., Curtis, L. J., Cunningham, C., Dunlop, M. G., Carothers, A. D., Morris, R. G., White, S., Bird, C. C., and Wyllie, A. H. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene, 12: 2641-2649, 1996.
25. Lothe, R. A., Peltomaki, P., Meling, G. I., Aaltonen, L. A., Nystromlahti, M., Pylkkanen, L., Heimdal, K., Andersen, T. I., Moller, P., Rognum, T. O., Fossa, S. D., Haldorsen, T., Langmark, F., Brogger, A., de la Chapelle, A., and Borresen, A. L. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res., 53: 5849-5852, 1993.
26. Cawkwell, L., Li, D., Lewis, F. A., Martin, I., Dixon, M. F., and Quirke, P. Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology, 109: 465-471, 1995.
27. Lukish, J. R., Muro, K., Denobile, J., Katz, R., Williams, J., Cruess, D. F., Drucker, W., Kirsch, I., and Hamilton, S. R. Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann. Surg., 227: 51-56, 1998.
28. Sankila, R., Aaltonen, L. A., Jarvinen, H. J., and Mecklin, J. P. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology, 110: 682-687, 1996.
29. Kim, H. G., Jen, J., Vogelstein, B., and Hamilton, S. R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am. J. Pathol., 145: 148-156, 1994.
30. Ruschoff, J., Dietmaier, W., Luttges, J., Seitz, G., Bocker, T., Zirngibl, H., Schlegel, J., Schackert, H. K., Jauch, K. W., and Hofstaedter, F. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am. J. Pathol., 150: 1815-1825, 1997.
31. Risio, M., Reato, G., di Celle, P. F., Fizzotti, M., Rossini, F. P., and Foa, R. Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res., 56: 5470-5474, 1996.
32. Krishna, M., Burgart, L. J., French, A. J., Moon-Tasson, L. L., McDonnell, S. K., Schaid, D. J., and Thibodeau, S. N. Predictive value of histopathology for mutator phenotype (microsatellite instability) in colorectal carcinoma. Gastroenterology, 112: A595, 1997.
33. Krishna, M., Burgart, L. J., French, A. J., Moon-Tasson, L., Halling, K. C., and Thibodeau, S. N. Histopathological features associated with microsatellite instability in colorectal carcinomas. Gastroenterology, 110: A546, 1997.
34. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
35. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1996.
36. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., and Tanabe, T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem., 270: 24965-24971, 1995.
37. Gou, Q., Liu, C. H., Ben-Av, P., and Hla, T. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem. Biophys. Res. Commun., 242: 508-512, 1998.
38. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996.
39. Sheng, H., Shao, J., Hooton, E. B., Tsujii, M., DuBois, R. N., and Beauchamp, D. R. Cyclooxygenase-2 induction and transforming growth factor β growth inhibition in rat intestinal epithelial cells. Cell Growth Differ., 8: 463-470, 1997.
40. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-400, 1996.
41. Ciardiello, F., Kim, N., Saeki, T., Dono, R., Persico, M. G., Plowman, G. D., Garrigues, J., Radke, S., Todaro, G. J., and Salomon, D. S. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. Natl. Acad. Sci. USA, 88: 7792-7796, 1991.
42. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
43. Korinek, V., Barker, N., Morin, P. J., Vanwichen, D., Deweger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. Constitutive transcriptional activation by a β-catenin-TCF complex in APC(-/-) colon carcinoma. Science (Washington DC), 275; 1784-1787, 1997.
44. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-TCF siganling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
45. Williams, C. S., Shao, J., Sheng, H., Radhika, A., and DuBois, R. N. Transcriptional regulation of cyclooxygenase-2 in intestinal epithelial cells. Gastroenterology, 112: A680, 1997.
46. Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
47. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, RS, Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
48. Olschwang, S., Hamelin, R., Laurent-Puig, P., Thuille, B., De Rycke, Y., Li, Y. J., Muzeau, F., Girodet, J., Salmon, R. J., and Thomas, G. Alternative genetic pathways in colorectal carcinogenesis. Proc. Natl. Acad. Sci. USA, 94: 12122-12127, 1997.
49. Ahuja, N., Mohan, A. L., Li, Q., Stolker, J. M., Herman, J. G., Hamilton, S. R., Baylin, S. B., and Issa, J. P. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res., 57: 3370-3374, 1997.
50. Kane, M. F., Loda, M., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., and Kolodner, R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 57: 808-811, 1997.
51. ink4A alleles in neoplasia. Cancer Res., 58: 591-593, 1998.
52. Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C-Y., Roche, P. C., Burgart, L. J., and Thibodeau, S. N. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res., 58: 3455-3460, 1998.
53. Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J. P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., Kane, M. F., Kolodner, R. D., Vogelstein, B., Kunkel, T. A., and Baylin, S. B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA, 95: 6870-6875, 1998.
54. 1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56: 733-737, 1996.
55. Chan, T. A., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-686, 1998.
56. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
57. Williams, C. S., Smalley, W., and DuBois, R. N. Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest., 100: 1325-1329, 1997.